1. Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study. Issue 2 (7th September 2022) Authors: Adotévi, Olivier; Vernerey, Dewi; Jacoulet, Pascale; Meurisse, Aurélia; Laheurte, Caroline; Almotlak, Hamadi; Jacquin, Marion; Kaulek, Vincent; Boullerot, Laura; Malfroy, Marine; Orillard, Emeline; Eberst, Guillaume; Lagrange, Aurélie; Favier, Laure; Gainet-Brun, Marie; Doucet, Ludovic; Teixeira,... Journal: Journal of clinical oncology Issue: Volume 41:Issue 2(2023) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗